← Eichor
Condition: Fibroblast Growth Factor 23 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Fibroblast Growth Factor 23

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Fibroblast Growth Factor 23 and Risk of Cardiac Arrhythmias in Hemodialysis Patients
Phase N/A · 1 location(s) · Antonio Bellasi · NCT06668831Right Ventricular Function Changes After CIED Implantation: The RIGHT-CIED Study
Phase N/A · 1 location(s) · Istanbul University - Cerrahpasa · NCT07272395Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients
Phase N/A · 13 location(s) · Kyowa Kirin Korea Co., Ltd. · NCT06202027Effective Dosing of Burosumab in XLH
Phase N/A · 1 location(s) · University of Nottingham · NCT07183579FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.
Phase N/A · 1 location(s) · Maimónides Biomedical Research Institute of Córdoba · NCT05356325Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome
Phase 4 · 9 location(s) · Fundación para la Investigación del Hospital Clínico de Vale · NCT07476859Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management
Phase N/A · 1 location(s) · Medical University of Gdansk · NCT06571344Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Phase N/A · 1 location(s) · Wake Forest University Health Sciences · NCT04752293
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.